Tag: Manufacturing
Cell Biobanks Are Critical For Organoids, Organ-On-Chips, And Additive Manufacturing
While the original 2D cell culture methods remain indispensable for routine laboratory operations and biochemical analyses it has become increasingly clear that they do not accurately represent organ systems in the body. To fully understand a system or device...
ExCellThera And NYBC’s Comprehensive Cell Solutions Enter Manufacturing Agreement
ExCellThera Inc., an advanced clinical stage biotechnology
company delivering molecules and bioengineering solutions to expand stem and
immune cells for therapeutic use, has announced that it has entered into a
manufacturing and collaboration agreement with Comprehensive Cell Solutions
(CCS), a division of New...
Cellect Biotechnology Completes Scale-Up Of Clinical Grade FasL; Enabling Stem Cell Therapy
Cellect Biotechnology Ltd. has announced that it has concluded the scale-up development and manufacturing of clinical grade FasL in collaboration with its outsourced supplier.
Founded in 2011, located in Tel Aviv, Isreal, Cellect Biotechnology has developed a breakthrough technology for...
Global Cooling Inc.’s Innovative Stirling Ultracold Ultra-Low Temperature Freezers Secure Funding
Global Cooling Inc., developer and manufacturer of Stirling
Ultracold ultra-low temperature (ULT) freezers featuring the innovative
free-piston Stirling engine cooling system, has announced that it has secured
Series B funding, led by Ohio Innovation Fund (OIF). Stirling Ultracold will
use the investment for...
LakePharma’s cGMP Plasmid MicroBiomanufacturing Center Is Now Operational
LakePharma Inc., the leading US-based biologics company
specializing in antibody & protein engineering, cell line development, and
protein production, has announced that their cGMP microBiomanufacturing™ Center
is now commercially manufacturing plasmid DNA at their Hopkinton, MA location,
which is in close proximity to...
Pluristem’s Point-Of-Care Thawing Device To Be Manufactured And Distributed By Chart Industries
Pluristem Therapeutics Inc., has announced that it has entered into a license agreement with a subsidiary of Chart Industries, Inc., regarding Pluristem’s thawing device for cell-based therapies. Pluristem Therapeutics Inc., founded in 2003, headquartered in Haifa, Israel, is a...
Orgenesis And Hemogenyx Collaborate To Manufacture Hu-PHEC Regenerative Technology
Orgenesis Inc. and Hemogenyx Pharmaceuticals PLC. are collaborating to develop and commercialize Hemogenyx’s Human Postnatal Hemogenic Endothelial (Hu-PHEC) technology.
Founded in 2008, headquartered in Germantown, Maryland, USA, Orgenesis is a vertically-integrated biopharmaceutical company with expertise and unique experience in cell...
